Generation and characterization of two novel monoclonal antibodies produced against human TLT-2 molecule

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 32, Issue 3, 2013, Pages 216-223

  Xu, Jun Chi ^a   Gao, Fei ^b   Fu, Feng Qing ^b   Chen, Yong Jin ^b   Xu, Ping ^a   Zhou, Bin ^b   Zhang, Xue Guang ^b  

^a The Affiliated Infectious Diseases Hospital of Soochow University   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10F5; MONOCLONAL ANTIBODY 8C10; PROTEIN ANTIBODY; TREM LIKE TRANSCRIPT 2 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; CELL LINE, TUMOR; CELL PROLIFERATION; EPITOPES; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 84881574242     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2012.0086     Document Type: Article

References (29)

1. Natarajan K, Dimasi N, Wang J, Mariuzza RA, and Marqulies DH: Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002;20: 853-885.
2. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, and Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. PNAS 2000;97: 13766-13771.
3. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, and López-Botet M: The TLT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29: 277-283.
4. Rajagopolan S, Winter CC, Wagtmann N, and Long EO: The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol 1995;55: 4143-4146.
5. Medzhitov R: Toll-like receptor and innate inmmnity. Nat Rev lmmunol 2001;1: 135-145.
6. Akira S, Takeda K, and Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Rev lmmunol, 2001;2: 675-680.
7. Wilson M J, Torkar M, Haude A, Milne S, Jones T, Sheer D, Beck S, and Trowsdale J: Plasticity in the organization and sequences of human KIR/ILT gene families. PNAS 2000;97: 4778-4793.
8. Torkar M, Haude A, Milne S, Beck S, Trowsdale J, and Wilson MJ: Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7-kbp deletion. Eur J Immunol 2000;30: 3655-3662.
9. Martin AM, Freitas EM, Witt CS, and Christiansen FT: The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 2000;51: 268-280.
10. Bahram S, Bresnahan M, Geraghty DE, and Spies T: A second lineage of mammalian major histocompatibility complex class I genes. PNAS 1994;91: 6259-6263.
11. Radosaveljevic M, Cuillerier B, Wilson MJ, Clément O, Wicker S, Gilfillan S, Beck S, Trowsdale J, and Bahram S: A cluster of ten novel MHC class I related genes on human chromosome 6q24.2.-q25.3. Genomics 2002;79: 114-123.
12. Lanier LL, and Bakker AB: The ITAM-bearing transmembrane adaptor DAP-12 in lymphoid and myeloid cell function. J Immunol 2000;12: 611-614.
13. Allcock RJ, Barrow AD, Forbes S, Beck S, and Trowsdale J: The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 2003;33: 567-577.
14. Bouchon A, Dietrich J, and Colonna M: Cutting edge: inflammatory responses can be triggered byTREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;10: 4991-4995.
15. King RG, Herrin BR, and Justement LB: Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation J Immunol 2006;176: 6012-6021.
16. Halpert MM, Thomas KA, King RG, and Justement LB: TLT2 potentiates neutrophil antibacterial activity and chemotaxis in response to G protein-coupled receptor-mediated signaling. J Immunol 2011;87: 2346-2355.
17. Kobori H, Hashiguchi M, Piao J, Kato M, Ritprajak P, and Azuma M: Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counterreceptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. J Immunol 2010;130: 363-373.
18. Leitner J, Klauser C, Pickl WF, Stockl J, Majdic O, Bardet A, Kreil DP, Dong C, Yamazaki T, Zlabinger G, Pfistershammer K, and Steinberger P: B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML-2 interaction. Eur J Immunol 2009;39: 1754-1764.
19. Tran CN, Thacker SG, Louie DM, Oliver J, White PT, Endres JL, Urquhart AG, Chung KC, and Fox DA: Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol 2008;180: 2989-2998.
20. Zhang G, Hou J, Shi J, Yu GB, and Zhang X: Soluble CD276(B7-H3) is released from monocytes, dendritic cells and activated T cell and is detectable in normal human serum. Immunology 2008;123: 538-546.
21. Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, Tan Y,Wang HT, Lu BF, and Zhang XG: Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 2010;59: 1163-1171.
22. Zhang G, Wang J, Kelly J, Gu G, Hou J, Zhou Y, Redmond HP, Wang JH, and Zhang X: B7-H3 augments the inflammatory response and is associated with human sepsis. J Immunol 2010;185: 3677-3648.
23. Masaaki A, Hashiguchi M, Hiroko H, Kamimura Y, Kozono H, and Azuma M: Triggering receptor expressed on myeloid cell-like transcript (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. PNAS. 2008;30: 10495-10500.
24. Hashiguchi M, Inamochi Y, Nagai S, Ostuki N, Piao J, Kobori H, Kanno Y, Kojima H, Kobata T, and Azuma M: Human B7-H3 binds to triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses. Open J Immunol 2012;2: 9-16.
25. Qiu YH, Sun ZW, Shi Q, Su CH, Chen YJ, Shi YJ, Tao R, Ge Y, and Zhang XG: Apoptosis of multiple myeloma cells induced by agonist monoclonal antibody against human CD28. Cell Immunol 2005;236: 154-160.
26. Chen YJ, Hu ZH, Wang Q, Ge Y, Bai LX, Wang XF, and Zhang X: Generation and characterization of four novel monoclonal antibodies against human programmed death-1 molecule. Hybridoma 2010;29: 153-160.
27. Lenschow DJ, Walunas TL, and Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14: 233-258.
28. Greenwald RJ, Freeman GJ, and Sharpe AH: The B7 family revisited. Annu Rev Immunol 2005;23: 515-548.
29. Dotti G: Blocking PD-1 in cancer immunotherapy. Blood 2009;114: 1457-1458.